Brief: Ecor1 Capital Reports 8.5% Passive Stake In Mirati Therapeutics, Inc. As Of Sept. 22-SEC Filing
02/10/2023 21:13
Oct 2 (Reuters) - Mirati Therapeutics Inc MRTX.O :
* ECOR1 CAPITAL, LLC REPORTS 8.5% PASSIVE STAKE IN MIRATI
THERAPEUTICS, INC. AS OF SEPTEMBER 22-SEC FILING
Further company coverage: MRTX.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Mirati Therapeutics
See all newsBrief: European Commission Approves KRAZATI As A Targeted Treatment For Non-Small Cell Lung Cancer
US FDA turns down Amgen lung cancer drug Lumakras for full approval (updated)
US FDA turns down Amgen lung cancer drug Lumakras for full approval
Brief: Mirati Stockholders Voted 'For' Proposal To Adopt Deal Between Co, Bristol-Myers Squibb
Mirati's lung cancer drug gets EU's regulatory backing (updated)